Arab League Belgique Luxembourg English - UK English - Ireland Romania Brasil México Deutsch Portuguese Suisse English - US Italiano Español Français

In this page we introduce an interview to Enzo Di Maio M.D., made by our scientific team

 

Question: Which are the causes that provoke Psoriasis?

 

Answer of the Enzo Di Maio, M.D.: Once that it has happened the conception has the formation of a new DNA (genetic code), where the necessary information to the life of the individual will be written all. In the DNA they are present the highest number of geniuses. The geniuses are containing parts of DNA one specific information, like the colour of the eyes or hats. Many diseases have root in the genetic predisposition of the individual. The nature of these pathologies is based on the correlation of numerous geniuses between of they. Therefore we can assert that many diseases have one base of poligenical predisposition.

 

In this context we find very many pathologies between which psoriasis, seborrhoic dermatitis, vitiligo, many dermatitis you, diabetes of the adult, rheumatoid arthritis, Psoriasis Arthritis, lupus, many thyroid like the thyroid ones of Hashimoto, essential the arterial hypertension, disease of Crohn or the regional ileitis, the colitis rectum and many others. In the interrelation between the geniuses it is written to you if that subject is predisposed, in the future, to become ill itself of one rather than of an other disease. In some cases they can more be present than one pathology in the same subject. In the course of the life of the individual, there is, inevitable, an  accumulate of toxins had to various causes. We can subdivide them in inside causes and outside causes.

 

The inside causes are in the wrong feeding, in what we drink, in the air that we breathe and from the atmosphere in which we live, comprised the causes chemistries and/or physics like toxic substances (assumed drugs, toxic presents in the surrounding atmosphere, radiations, etc). For the outside causes we must consider the interface of that individual with the world that encircles it, that is its microcosm. Therefore all that that the person encircles, like the working, familiar, scholastic atmosphere, the economic side, etc can carry to having of the thoughts denied to you. These stressful factors are translate, in the individual, an increase of toxins.

 

A negative thought can be poisinous than a poisoned food. It is not of agreement? ... (continuing)… All that involves a situation of stress beyond the physiological one in the organism .Therefore will form a sure toxin number and once accumulated in excess they will be manifested with the present predispositions in the DNA of that individual. Therefore the age in which an other pathology will be able to be manifested or will depend is from how many toxins is accumulated and is from the same predisposition of the subject.

 

Question: How is it possible to cure or to make to revert the psoriasis?

 

Answer of the Enzo Di Maio, M.D.: Premised the made speech previously, it appears clearly that we can subdivide the possibilities in two great lines. Before it could be local and the second one will be general. Like all healthy good, they exist in commerce numerous produced topical made up of cortisone and of other substances chemistries, of insufficient or null effectiveness.

 

While it can be stated, in base to personal experiences, a remarkable effectiveness in natural products, that moreover they are optimally tolerated. These natural products can be use you alone also, also because they do not need of medical prescription. All do not have want and/or the possibility and/or the necessity to it to carry the general aspect ahead.

 

Question: Can explain us the aspects from the general point of view?

 

Answer of the Enzo Di Maio, M.D.: The cure from the general point of view normally previews the use of immunosoppressori or also it calls to you immunomodulatori. Personally they are not at all of agreement with I use it of these substances in these pathologies. To my opinion, for being able to raise a depressed immune system we must in the first place eliminate the greater toxin amount and bring back to the equilibrium the same individual.

 

Question: : How it is possible to bring back to the equilibrium an individual with problematic similar?

 

Answer of the Enzo Di Maio, M.D.: A closely personal approach will have to be faced. As it says the saying that all how many know "cannot be made of all the grass a bundle", the causes that in that individual, have carried to the disease, and therefore to the imbalance, are of the all personal, even if pathology is introduced identical or similar in other individuals. For every individual it is various, has a different DNA.

 

Therefore the answer to stressful factors could not be the same one. After more than twenty years than studies care the present medicines in the world I have been able to state the correctness and the effectiveness of the philosophy of the ayurvedica medicine. The ayurvedica medicine places to the middle of its philosophy the individual, that it has or more problematic and leaving from that finds like, in that case, us will have to be involved, to the therapeutic level, in order to find again the lost equilibrium and therefore the health.

 

Question: To practical level, as it will be able to make a person that desires to resolve its regarding problems of health pathologies of which it has spoken to us previously like the psoriasis, the seborrhoic dermatitis , the vitiligo, the dermatitis you, the diabetes of the adult, the rheumatoid arthritis, the Psoriasis Arthritis, the lupus, the thyroid ones of Hashimoto, essential the arterial hypertension, the disease of Crohn, the colitis rectum?

 

Answer of the Enzo Di Maio, M.D.: It is necessary, with an taken care of visit, to know the individual in all the aspects comprised its constitution. Then it will be attempted to characterize the probable causes that are to the root of the problematic ones of the subject. Once fact this will be able to be begun to construct that one that could be the personal therapy.

 

In great lines, it can be said that, one will begin with one first phase of Detoxification, that is elimination of the greater possible toxin number. Then personal correct feeding will be constructed one. It sees.... the philosophy of the ayurvedica medicine considers the alimony like drugs. According to the ayurvedica medicine the food will have to be in agreement with the person who eats it.

 

This speech would be along exposing hour, will be able to send back it to an other eventual interview. Returning to the argument in issue, therefore beyond to an feeding studied to personal level for that individual, in that moment of its life, with its problematic ones it will be able to beprescribed of the supplements specific and variable, useful to find again the equilibrium and the same health.

 

Question: For how much time this therapeutic approach must be carried ahead?

 

Answer of the Enzo Di Maio, M.D.: Normally it is succeeded to having of the optimal ones turns out to you in approximately two months. Obviously they exist of the cases that need of a longer time in function of the specific causes and the same subject. any case, if the individual in issue, behaves itself correctly, the improvement is progressive and happens day after day. Therefore one is it stimulates to you and it motivates to you to follow with thoroughness the therapy. In the case in which a general approach is wanted to be followed it is necessary to be you follow yourself from a good doctor.

 

After you have proved all drugs (cortisone, immunosuppressive, puva and various therapies)

and you have seen that they don't work, you know that Shivax® exists! We are here to help you

 


 

Interview RAI, Mi Manda RAI 3 to Dr. Enzo DI MAIO

 

 

This interview has been realized from the scientific writing of the Shivax s.r.l. and all the rights reserved. In the case desires to be published all or leave of this interview are necessary to obtain from the Shivax s.r.l. a written consent

 

 

Dr. Enzo DI MAIO

This article has been written with the scientific collaboration of Dr. Enzo DI MAIO, that from more than 30 years pratices successfully these methods.
For another technical, scientific or practical informations, you can call us at our numbers that you find at the end of the page

The 100% Natural Solution for Baldness


in the World

U.K. (London)
+44.(0)2035298053
Svizzera (Ginevra)
+41-225331280
France (Paris)
0800-910-952
España (Madrid)
+34.91.1516463
Mexico (Monterrey)
+52.81.46244658
U.S.A. (Manhattan)
+1-212-710-5603
U.S.A. (Miami)
+1-786-523-0412
U.S./Canada (Toll Free)
1-800-491-6104
Ireland (Dublin)
+353-15262551
Colombia (Toll Free)
01.800-915-5681
Brasil (São Paulo)
+55-1139570424
Venezuela (Caracas)
+58-212-6300744
Argentina (Buenos Aires)
+54-1166322081
           
Cure Skin Alopecia Candida Ayurvedic Medicine Interviews

  Psoriasis and Photos   Areata Alopecia   Candida Man   What is?   to Dr. DI MAIO about Psoriasis
  Seborrheic Dermatitis   Androgenetic Alopecia   Candida Woman   Interview RAI   to Dr. DI MAIO about Candida
  Atopic Dermatitis   Interview to Dr. DI MAIO   Intestinal Candida   Constitution Test   to Dr. DI MAIO about Baldness
  Contact Dermatitis   Alopecia Man   Genital Candida   Preliminary Tests   to Dr. DI MAIO
  Lichen   Alopecia Woman   Irritable Bowel   Lose Weight & Ayurveda   to Dr. DI MAIO on RAI 3
  Acne   Clinical Trial about Alopecia   Recurrent Cystitis   Reiky   Dr. DI MAIO's Method
  Eczema Arthritis Woman   Kinesiology Clinical Trials  
  Erythema Baby   Psoriatic Arthritis   Menopause   Flowers of Bach   Clinical Study about Psoriasis Dr.  Enzo DI MAIO
  Herpes   Rrheumatoid Arthritis   Dyspareunia   Diabetes I and II   Certifications in Spain
  Psoriatic Arthritis     Painful Sexual Intercourses   Metabolic Syndrome   Certifications in Brazil
  Photos Psoriasis         Panic Attacks- DSP   Clinical Study about Alopecia
  Treatment Psoriasis              
  Clinical Trial about Psoriasis              
Personal Protocols Dietary Advice Shivax® Store Showroom Franchising Shivax® Store
Where we are Specialist Medical Center Products Site Map How to Shop Shivax®
          Facebook Enzo Di Maio

Send an E-Mail to  info@shivax.com for questions or comments on this Website

Shivax International Ltd , 145 - 147 St. John Street EC1V 4PW London UK Register Number 07192591
London UK, from other country +44.2035298053 and +44.02035298053 from UK

© C o p y r i g h t   1 9 9 5   -   A l l   R i g h t s   R e s e r v e d

 

BIBLIOGRAPHY

Iwata, K.; Yamamoto, Y. Glycoprotein Toxins Produced by Candida albicans. Proceedings of the Fourth International Conference on the Mycoses, PAHO Scientific Publication #356, June 1977.
Quiralte, J.; Blanco, C.; Esparaza, R.; Castillo, R. Carrillo, T. Nasal Candidiasis in an Immunocompetent Patient. Allergologia et Immunopathologia. 21(6):227-8, 1993 Nov.-Dec.
Magnavita, N. Mucocutaneous candidiasis in exposure to biological agents: a clinical case. Medicina del Lavoro. 84(3):243-8, 1993 May-Jun. (in Italiano)
Gutierrez, J.; Maroto, C.; Piedrola, G.; Martin, E.; Perez, JA. Circulating Candida antigens and antibodies: useful markers of candidemia. Journal of Clinical Microbiology. 31(9):2550-2, 1993 Sep.
Walsh, TJ.; Lee, JW.; Sien, T.; Schaufele, R.; Bacher, J.; Switchenko, AC.; Goodman, TC.; Pizzo, PA. Serum D-arabinitol measured by automated quantitative enzymatic assay for detection and therapeutic monitoring of experimental disseminated candidiasis: correlation with tissue concentrations of Candida albicans. Journal of Medical & Veterinary Mycology. 32(3):205-15, 1994.
Switchenko, AC. Miyada, CG. Goodman, TC. Walsh, TJ. Wong, B. Becker, MJ Ullman, EF. An automated enzymatic method for measurement of D-arabinitol, a metabolite of pathogenic Candida species. Journal of Clinical Microbiology. 32(1):92-7, 1994 Jan.
Hussain, G.; Galahuddin, N.; Ahmad, I.; Galahuddin, I.; Jooma, R. Rhinocerebral invasive mycosis: occurrence in immunocompetent individuals. European Journal of Radiology. 20(2):151-5, 1995 Jul.
Cater, RE., 2nd Chronic candidiasis as a possible etiological factor in the chronic fatigue syndrome. Medical Hypotheses. 44(0):507-15 Jun. 1995
Crook, WG. The Yeast Connection Professional Books, Jackson Tennessee
Crook, WG. The Yeast Connection and the Woman. Professional Books, Jackson Tennessee
Di Maio E, M.D. Ayurveda contro i disturbi della donna. Silhouette, 3D Editoriale, Anno 5°, Numero 4, Aprile 1998, Milano .
Di Maio E, M.D. Reiki, Ayurveda, alimentazione ed altro. Puntoluce, Anno 11°, Numero 41, Primavera 1998, Milano.
Di Maio E, M.D. Rivista Mensile "FOCUS" n. 80 del Giugno 1999, Mondadori
Di Maio E., M.D. Rivista Settimanale "GRAZIA" n. 14 del 10  Aprile 2001, Mondadori
Di Maio E, M.D. Come diagnosticare le infezioni da Candida albicans. Polizia Sanitaria, DCB, Anno 12°, Numero 75, 2004, Milano
Widder, RA.; Bartz-Schmidt, KU.; Geyer, IL.; Brunner, R.; Kirchhof, B.; Donike, M.; Ileinmann, K. Candida albicans endophthalmitis after anabolic steroid abuse (letter). Lancet. 345(8945):330-1, 1995 Feb 4.
Ross, VE.; Baxter, DL. Widespread Candida Folliculitis in a Nontoxic Patient. Cutis. 49(1):241-243, 1992 April.
Cater, RE. Somatization disorder and the chronic candidiasis syndrome: a possible overlap. Medical Hypotheses. 35:126-135, 1991.
Kroker, GF. Chronic Candidiasis and Allergy. In: Brosteff J.; Challacombe SJ.;eds. Food Allergy and Intolerance. London:Baillierre Tindall, 1989: ch. 49.
Kirkpatrick, CH.; Smith, TK. Chronic mucocutaneous candidiasis: immunologic and antibiotic therapy. Annals of Internal Medicaine. 80: 310-320, 1974.
Dismukes, WE., Way, JS., Lee, JY., Dockery, B.K., Hain, J.D., A randomized double-blind trial of nystatin therapy for the candidiasis hypersensitivity syndrome. New England Journal of Medicine. 323:1717-23, 1990.
Bennett, JE. Searching for the yeast connection. New England Journal of Medicine. 323:1766-67, 1990.
Zwerling, MH., Owens, KN., Ruth, NH. Think yeast-the expanding spectrum of candidiasis. Journal of the South Carolina Medical Association. 80:454-456, 1984.
Mangani V.,Panfili A., Candida l'epidemia silenziosa:allergia al XX secolo? ed.Tecniche Nuove 1996.
Mangani V.,Panfili A.,La dieta ph ed.       Tecniche Nuove 1997.
Panfili A., Medicina Ortomolecolare.ed Tecniche Nuove 1994
Truss, CO. The role of candida albicans in human illness. Journal of Orthomolecular Psychology. 10:228-238, 1981.
Truss, CO. Tissue injury induced by candida albicans. Journal of Orthomolecular Psychology. 7(1)
Truss, CO. Restoration of immunologic competence to candida albicans. Journal of Orthomolecular Psychology. 9(4)
Truss, CO. Metabolic abnormalities in patients with chronic candidiasis: the acetaldehyde hypothesis. Journal of Orthomolecular Psychology. 13(2):66-93
Bodey, G., Fainstein, V., Garcia, I., Rosenbaum, B., Wong, Y. Effect of broad-spectrum cephalosporins on the microbial flora of recipients. The Journal of Infectious Diseases. 148:892-897, 1983.
Giuliano, M., Barza, M., Jacobus, N., Gorbach, S. Effect of broad spectrum antibiotics on composition of intestinal microflora of humans. Antimicrobial Agents and Chemotherapy. 202-206, 1987.
Gracey, M., Burke, V., Thomas, J. Stone, D. Effect of microorganisms isolated from the upper gut of malnourished children on intestinal sugar absorption in vivo The American Journal of Clinical Nutrition. 28:841-845, 1975.
Eras, P., Goldstein, M., Sherlock, P. Candida infection of the gastrointestinal tract. Medicine 51(5):367-379, 1972.
Trowbridge, J.P., Walker, M. The Yeast Syndrome. Bantam Books. New York, 1986.
Hotopf, Matthew. Seasonal affective disorder, environmental hypersensitivity and somatisation. British Journal of Psychiatry. 164: 246-248, Feb. 1994.
Keith, Sehnert W. Candida-related complex (CRC), a complicating factor in treatment and diagnostic screening for alcoholics: A pilot study of 213 patients. International Journal of Biosocial and Medical Research. 13(1):67-76, 1991.
Rogers, Sherry A. Healing from the inside out: The leaky gut syndrome. Let's Live. 63(4):34-38, Apr 1995.
Neuro-Immunophysiology of the Gastrointestinal Mucosa.
Annals of the New York Academy of Sciences. 664, 1992
Shorter, RB. Kirsner, JB. Gastrointestinal Immunity for the Clinician. Grune & Stratton, Inc., Orlando, FL. 1985
Murray, F. Acidophilus fights fungal infections. Better Nutrition for Today's Living. 56(5):54-55, May 1994
Palmer, CA. A yeast for all reasons or is candidiasis the hidden enemy? Nutrition Today. 28(3)24-29, May 1993
Yeast can destroy friendly bacteria.
USA Today: The Magazine of the American Scene. 122(2585):6-7, Feb. 1994
Hentges, David J. Human intestinal microflora in health and disease. Academic Press: NY, 1983
Hill, MJ. Role of gut bacteria in human toxicology and pharmacology. Taylor & Francis: Bristol, PA, 1995.
Rowland, IR. Role of the gut flora in toxicity and cancer. Academic Press:San Diego, 1988
Brostoff, J. Challacombe, SJ. Food Allergy and Intolerance. Bailliere Tindall: Philadelphia.
Winner, HI. Hurley, R. Symposium on Candida Infections. E & S Livingstione LTD: London, 1966
James, J. Warin, RP. An assessment of the role of Candida albicans and food yeasts in chronic urticaria. British Journal of Dermatology. 84:227-237, 1971
Schinfeld, JS. PMS and candidiasis: study explores possible link. The Female Patient. 12:July 1987
Witkin, SS. Defective immune response in patients with recurrent candidiasis. Infections in Medicine. May-June 1985
Resseger, Charles S., D.O. or Norwalk, OH. Conversations with
Giannela, RA. Broitman SA. Zamcheck, N. Influence of gastric acidity on bacterial and parasitic enteric infections: a perspective. Annals of Internal Medicine. 78: 271, 1973
Gordon, JE. Chitkara, ID. Wyon, JB. Weanling diarrhea. American Journal of Medical Science. 245:345, 1963
Mackowiak PA. The Normal Microbial Flora. New England Journal of Medicine. 307:83, 1982
Freter, R. Interactions between mechanisms controlling the intestinal microflora. American Journal of Clinical Nutrition. 27:1409, 1974
Bartlett, JG. Antibiotic associated pseudomembranous colitis. Rev Infect Dis. 1:123, 1979
Freter, R. Brickner, H. Botney, M. et al. Mechanisms that control bacterial populations in continuous flow culture models of mouse large intestinal flora. Infectious Immunology. 39:676, 1983
Shedlofsky, S. Freter, R. Synergism between ecologic and immunologic control mechanisms of intestinal flora. Journal of Infectious Diseases. 137:661, 1978
Renfro, L. Feder, HM Jr. Lane, TJ. Manu, P. Matthews, DA. Yeast connection among 100 patients with chronic fatigue. American Journal of Medicine. 86(2):165-8, Feb. 1989.
Schlossberg, D. Devig, PM. Travers, H. Kovalcik, PJ Mullen, JT. Bowel perforation with candidiasis. Journal of the American Medical Association. 238(23):2520-1, Dec 5, 1977.
Schwartz, RH. Knerr, RJ. Candida esophagitis during treatemnt for adolescent acne vulgaris. Pediatric Infectious disease. 1(5):374, Sep-Oct, 1982.
Jayagopal, S. Cervia, JS. Colitis due to Candida albicans in a patient with AIDS. Clinical Infectios Diseases. 15(3):555, Sep. 1992.
Minoli G. Terruzzi V. Butti G. Frigerio G. Rossini A. Gastric candidiasis:an endoscopic and histological study in 26 patients. Gastrointestinal endoscopy. 28(2)59-61, 1982.
Tortora, G. Funke, B. Case, C. Microbiology. New York: Benjamin/Cummings Publishing Company, 1995.
Saltarelli, Cora G. Candida albicans: The Pathogenic Fungus. Hemisphere Publishing Company: Philadelphia, 1989.
Segal, Esther; Baum, Gerald L. Pathogenic Yeasts and Yeast Infections. CRC Press: Ann Arbor, 1994.
Jenzer, Martin, M.D. or Rochester, NY. Conversations with.
Nelson, Robert S. Bruni, Hamilton C. Goldstein, Harvey M. Primary gastric candidiasis in uncompromised subjects. Gastrointestinal Endoscopy. 22:2, 92-94, 1982.
Chan, Stephen, PhD, of SUNY College at Brockport, NY. Conversations with.
Discussions with patients that have been treated with antifungal and diet therapy.

Candida and Psoriasis in Dermatological Disease

Skinner, RB. Jr. Rosenberg, W. Noah, PW. Psoriasis of the palms and soles is frequently associated with oropharyngeal Candida albicans. Acta Dermatological Venereol Supplement. 186:149-150, 1994.
M buslau, Menzel I, Holzmann H. Fungal flora of the human faeces in psoriasis and atopic dermatitis. Mycoses. 33:2, 90-4, Feb. 1990.
Soyeur U. Kilic H. Alpan O. Anti-Candida antibody levels in psoriasis vulgaris. Cent. Afr. Journal of Medicaine. 36: 8, 190-2, Aug. 1990.
Baker BS. Powles AV. Malkani AK. Altered call-medicated immunity to group A haemolytic atreptococcal antigens in chronic plaque psoriasis. British Journal of Dermatology. 125: 1, 38-42, Jul 1991.
el-Maghrabi EA. Dixon DM. Burnett JW. Characterization of Candida albicans epidermolytic proteases and their role in yeast-cell adherance to keratinocytes. Clinical Experimental Dermatology. 15: 3, 183-91, May 1990.
Senff H. Bothe C. Busacker J. Reinel D. Studies on the yeast flora in patients suffering from psoriasis capillitii or seborrheic dermatitis of the scalp. Mycoses. 33:1, 29-32, Jan 1990.
Orkin VF. [The characteristics of the clinical picture of candidiasis of the skin and mucous membranes in patients with chronic dermatosis] - Russian. Vrach Delo. 5, 78-80, May 1992.
McKay M. Vulvar dermatoses: common problems in dermatological and gynecological practice. British Journal of Clinical Pract. Sym. Supplement. 71: 5-10, Sep 1990.
Noah PW. The role of microorganisms in psoriasis. Semin Dermatology. 9:4, 269-76, Dec 1990.
Haneke E. Fungal infections of the nail. Semin Dermatology. 10: 1, 41-53, Mar 1991.
Rosenberg, EW. Noah PW. Skinner RB. Microorganisms and psoriasis. Journal of the National Medical Association. 86:4, 305-10, Apr 1994.
Meinhof W. [Intestinal colonization with Candida albicans and its effect on chronic inflammatory dermatoses]-German. Hautarzt. 46:8, 525-7, Aug 1995.
Buslau L. Hanel M. Holzmann H. The significance of yeasts in seborrheic eczemna. Hautarzt. 40(10):611-3, Oct. 1989. - German
Henseler T. [Mucocutaneous candidiasis in patients with skin diseases] - German. Mycoses. 38 Supplement 1:7-13, 1995.
Kemeny L. Ruzicka T. Dobozy A. Michel G. Role of interleukin-8 receptor in skin. International Archives of Allergy and Immunology. 104: 4, 317-22, Aug 1994.
Squiquera L. Galimberti R. Morelli L. Plotkin L. Milicich R. Kowalckzuk A. Leoni J. Antibodies to proteins from Pityrosporum ovale in the sera from patients with psoriasis. Clinical Experimental Dermatology. 19: 4, 289-93, Jul 1994.
Oranje AP. Dzoljic-Danilovic G. Michel MF. Aarsen RS. van Joost, T. [Is juvenile seborrheic dermatitis a candidiasis? Studies of a possible link with microbial infections.] - German Tijdschrift voor Kindergeneeskunde. 55(3):87-92, Jul 1987.

Candida and Diarrhea

Burke, V., Gracey, M. An experimental model of gastrointestinal candidiasis Journal of Medical Microbiology. 13:103-110.
Gupta, T., Ehrinpreis, M. Candida-associated diarrhea in hospitalized patients. Gastroenterology. 98:780-785, 1990.
Danna, P., Urban, C., Bellin, E., Rahal, J. Role of candida in pathogenesis of antibiotic-associated diarrhoea in elderly inpatients. The Lancet. 337:511-514, 1991.
Bishop, R., Barnes, G. Depression of lactase acitivity in the small intestines of infant rabbits by Candida albicans.
Kane, J., Chretien, J., Garagusi, V. Diarrhoea caused by Candida The Lancet. 335-336, 1976. (Immunocompetent).
Garagusi, VF. Chretien, JH. Diarrhoea caused by Candida.(letter) Lancet. 1(7961):697-8, Mar 27, 1976.
Letter in Lancet in response. Enweani IB. Obi CL. Jokpeyibo M. Prevalence of Candida species in Nigerian children with diarrhoea. J.Diarrhoeal Dis Res 12(2):133-5, Jun, 1994.
Gut flora in normal and disordered states.
Chemotherapy. 5-15, 1995.
Vogel LC. Antibiotic-induced diarrhea. Orthop Nurs 14(2): 38-41, Mar-Apr, 1995.
Koffi-Akoua G. Ferly-Therizol M. Kouassi-Beugre MT. Konan A. Timite AM. Assi Adou J. Assale G. [Cryptosporidium and candida in pediatric diarrhea in Abidjan.] Bull Soc Pathol Exot Filiales 82(4): 451-7, , 1989.
Ngan PK. Khanh NG. Tuong CV. Quy PP. Anh DN. Thuy HT. Persistent diarrhea in Vietnamese children: a preliminary report. Acta Paediatric Supplement. 381: 124-6, Sep, 1992.
Siregar CD. Sinuhaji AB. Sutanto AH. Spectrum of digestive tract diseases 1985-1987 at the Pediatric Gastroenterology Outpatient Clinic of Dr. Pirngadi General Hospital, Medan. Paediatr Indones. 30(5-6): 133-8, May-Jun, 1990.
Talwar P. Chakrabarti A. Chawla A. Mehta S. Walia BN. Kumar L. Chugh KS. Fungal diarrhoea: association of different fungi and seasonal variation in their incidence. Mycopathologia. 110(2): 101-5, May, 1990.
Omoike IU. Abiodun PO. Upper small intestinal microflora in diarrhea and malnutrition in Nigerian children. Journal of Pediatric Gastroenterolog Nutrition 9(3): 314-21, Oct, 1989.

Immunosuppression

Hirschel B. [AIDS and gastrointestinal tract: a summary for gastroenterologists and surgeons] Schweiz Med Wochenschr. 120(14): 475-84, Apr 7, 1990.
Gage TP. Eagan J. Gagnier M. Diverticulitis complicated by candidal pylephlebitis. South Med. Journal 78(10): 1265-6, Oct, 1985.
Caselli M. Trevisani L. Bighi S. Aleotti A. Balboni PG. Gaiani R. Bovolenta MR. Stabellini G. Dead fecal yeasts and chronic diarrhea. Digestion. 41(3): 142-8, 1988.
Zhen DL. [Analysis of the causative organisms in adult acute infectious diarrhea encountered in the past 12 years]. Chung Hua Nei Ko Tsa Chih 21(9): 540-2, Sep, 1982.
Lorenz A. Grutte FK. Schon E. Muller B. Klimmt G. [Fungal infection of the small bowel mucosa.] Mykosen. 27(10): 506-10, Oct, 1984.

Candida and Antibiotics

[Clinical evaluation of a new oral penem, SY5555, in the pediatric field.] Japanese Journal of Antibiotics. 41-8, Jan, 1995.
Elmer GW. Surawicz CM. McFarland LV. Biotherapeutic agents: A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. Journal of the American Medical Association. 275(11): 870-6, Mar 20, 1996.